Amy J. Reisinger, Chief Executive Officer and Toxicologist, SteelFusion Clinical Toxicology Laboratory, LLC - Ms. Reisinger studied Biology/Pre-Medicine at The University of North Carolina in Wilmington, North Carolina and completed postgraduate studies for the Cardiovascular Perfusion Program at Duquesne University in Pittsburgh, Pennsylvania. Ms. Reisinger began her professional career as an Extra Corporeal Membrane Oxygenator (ECMO) Specialist and Histologist at Children’s Hospital of Pittsburgh, Pennsylvania, where she monitored patient’s hemodynamics following critical physician orders, and administered medications. Additionally, she supported the pathology and toxicology departments by conducting toxicology interpretations and assisting in the collection of pathological specimens during autopsy procedures. She became a Research Scientist at GlaxoSmithKline, Research Triangle Park, North Carolina, where she provided regulatory support to the pharmaceutical industry. Ms. Reisinger was responsible for performing the gross and microscopic examinations of animals utilized in toxicology studies as well as evaluating the significance of the anatomic and clinical pathology, as well as organ weight data from such studies. Additional responsibilities included: generating pathology interpretations to accurately reflect the data and provide significance for drug registration and drug safety; review study protocols and contribute to the design of pathologic evaluations; train necropsy technicians to conduct Good Laboratory Practice (GLP) compliant work utilizing Standard Operating Procedures (SOPs); and keeping abreast of current scientific literature in toxicological pathology. Ms. Reisinger is a Registered Histotechnician and Registered Histologist with the American Society of Clinical Pathologists. Based on her knowledge of toxicology and pathology and understanding the logistics of performing clinical studies in accordance with GLPs, Ms. Reisinger served as a Study Director/Monitor at Bristol-Myers Squibb Company in Mt. Vernon, Indiana for GLP and non-GLP toxicology studies, including investigative and mechanistic studies. She prepared schedules for study activities; conducted data reviews; evaluated scientific data to develop conclusions derived from the studies undertaken; prepared reports and summaries of toxicology studies; prepared safety/risk assessments for human health based on preclinical study results; ensured compliance with GLPs and SOPs, Quality Assurance, safety and animal welfare guidelines, and other state and federal regulations. Ms. Reisinger maintained knowledge of worldwide testing and registration requirements and initiated and monitored Contract Research Organization (CRO) studies. Additionally, Ms. Reisinger presented at scientific meetings and published papers in journals; participated in the investigation of complex toxicity findings encountered in nonclinical toxicity studies; maintained an excellence in knowledge and evaluation group through their application in drug discovery and development; critically evaluated Human and Veterinary Pharmaceuticals; prepared Safety Data Sheets (SDSs) and prepared Chemical Hygiene Plans (CHPs) for the safe handling of chemicals including test articles and formulation components. SteelFusion Clinical Toxicology Laboratory, LLC, was established in 2014 by Ms. Reisinger as a women-owned and operated toxicology laboratory specializing in clinical and forensic toxicology services. Amy has been serving as the President and CEO of the laboratory since its inception. She is a member of Women’s Business Enterprise National Council, Society of Toxicology, American College of Toxicology, International Association of Coroners and Medical Examiners, American Society Clinical Pathology, Project Management Institute, and National Society of Histotechnology. From 2016 through 2018, Ms. Reisinger was awarded three US Patents for the rapid and sensitive method of forensic toxicology in Post-mortem subjects using oral fluid testing. She has extensive experience and expertise working with WBENC, CLIA, CAP, DOH, OSHA, SHARP, ISO, ABFT, ANAB and other regulations and guidelines governing the use of chemicals and drugs in the marketplace. Ms. Reisinger performed Graduate Studies in Perfusion Technology, Duquesne University, Pittsburgh, PA, 1993 BS, Biology, University of North Carolina, Wilmington, Wilmington, NC, 1991. She is a Registered Histotechnician and Histotechnologist and is published in Neuropharm, Toxicologic Pathology, and Journal of the American Association Laboratory Animal Science. Ms. Reisinger is also a member of the Society of Toxicology, American College of Toxicology, American Association of Laboratory Animal Science, American Society for Clinical Pathology, National Society for Histotechnology, and Project Management Institute.
Toxicology, Forensic Toxicology, Analytical Chemistry
Aizman Roman Idelevich is Doctor of Biological Sciences, Professor, Honored Worker of Science of Russia, Head of the Department of Anatomy, Physiology and Safety, Director of the Institute of Health and Safety. He is a Member of 3 dissertation councils for doctoral theses, a Foreign Member of the American Physiological Society, a valid Member of the European Society of Pediatric Nephrology and an Associate Editor of two scientific journals. He is the author of over 500 scientific and methodical works, including 28 monographs, 90 manuals, 367 articles in refereed journals and 16 proposals, patents and registration certificates. He was awarded Diplomas of the Ministry of Education of the Russian Federation, Ministry of Emergency Situations, the Administration of the City and Region (Novosibirsk) the Medal Property of Siberia, K. D. Ushinsky Medal, etc
Developmental physiology, Renal physiology and water-salt homeostasis, Sports physiology, Psychophysiology
Dr. DeGarmo is a Professor Emerita at Southern Illinois University Edwardsville, USA and research associate for the Applied Research Institute in Jerusalem. Her expertise consists of international security with a focus on the nuclear era and security in the Middle East. She has also been a facilitator for the Foreign Policy's Great Decisions program at the university since 2001. Dr. DeGarmo previously spent several years as a department chair of the political science department at Southern Illinois University Edwardsville. A recipient of numerous research grants over the years, she has also received numerous awards for her contributions, including a Meridian Award for 2011 and 2012, and a Dr. Martin Luther King Jr. Humanitarian Award in 2011, all granted by Southern Illinois University Edwardsville. She has also been named as the recipient of the “Lifetime Achievement Award” and “Who’s Who of Professional Women” by Marquis in 2017. She also served on the Organizing Committee and as Keynote Speaker for “Environmental Toxicology and Ecological Risk Assessment”September 24-25, 2018 Chicago, Illinois, USA. Professor DeGarmo has authored four books, "The Geneva Conventions of 1949 and Their Protocols: The Case of Israel" in 2016, “The U.S.-Israeli Strategic Alliance and the Disappearing Palestine” in 2016, “The Disposal of Radioactive Wastes in the Metropolitan St. Louis Area: The Environmental and Health Legacy of the Mallinckrodt Chemical Works” in 2006, and “International Environmental Treaties and State Behavior: Factors Influencing Cooperation,” in 2004. She has also written a number of book chapters, contributions to both encyclopedias and professional journals, and undergraduate teaching manuals. Beyond those literary accomplishments, Dr. Degarmo has conducted over two dozen book and article reviews, and has served as a presenter and chair for many conference proceedings since 1994.
The nuclear era and security in the Middle East
B.S. degree in Fisheries (Marine Biology) from the University of Washington in 1968 and a Ph.D. in Pathology from the University of Oregon Medical School in 1972. He began his scientific career at the National Institute of Environmental Health Sciences prior to becoming Director of the University of Maryland System-wide Program in Toxicology and Professor at the University of Maryland School of Medicine. He then served as Associate Director for Science in the Division of Toxicology and Environmental Medicine at Agency for Toxic Substances and Disease Registry (ATSDR). He is currently an Adjunct Professor, Emory School of Public Health and Presidents Professor of Biomedical Science at the University of Alaska- Fairbanks. Dr. Fowler, is an internationally recognized expert on the toxicology of metals and has served on a number of State, National and International Committees in his areas of expertise. These include various expert committees of the National Academy of Sciences / National Research Council, the USEPA Science Advisory Board, US Pharmacopeia, World Health Organization and the Joint FAO/WHO Committee on Food Additives (JECFA). Dr. Fowler has been honored as a Fellow of the Japanese Society for the Promotion of Science (JSPS), a Fulbright Scholar and Swedish Medical Research Council Visiting Professor at the Karolinska Institute, Stockholm, Sweden and elected as a Fellow of the Academy of Toxicological Sciences. He has been elected to the Council of the Society of Toxicology, the Board of Directors of the Academy of Toxicological Sciences, and more recently, to the Council of the Society for Risk Analysis. Dr. Fowler is the author/editor of 8 books and author of over 260 research papers / book chapters dealing with molecular mechanisms of metal toxicity, use of molecular biomarkers for early detection of metal-induced cell injury and application of computational approaches for risk assessment. He has a received a number of awards for his scientific contributions and leadership including a Society of Toxicology Colgate-Palmolive Visiting Professorship in In-Vitro Toxicology, University of Washington, 1998- 9, CDC/NCEH/ATSDR Honor Award for Excellence in Leadership Award (Non- Supervisory)- December, 2010, CDC/NCEH/ATSDR Honor Award for Excellence in Quantitative Sciences Cadmium PBPK Modeling Group Award - December 2010, CDC/NCEH/ATSDR Honor Award for Excellence in Emergency Response Deepwater Horizon Oil Spill Response Team (Domestic) Group Award - December 2010, 2014 USP Award for an Innovative Response to Public Health Challenges (Group Award).
Veterinary medicine, Pathology, Veterinary infections
Dr. Alireza Heidari is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than two hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Italy, Austria, Hungary, Poland, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than seven hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than two hundreds reputed international academic–scientific–research institutes around the world. In addition, he is member of the Nobel committee for Chemistry. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.
Biomolecular spectroscopy, Nano Drugs, Nano Drugs Delivery, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues
Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an H-index of 64, (ResearchGate STATs (27), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4584. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations
Anti-Aging and Chronic Disease
Editorial membership ? Highlights clinical and cellular immunology heighpubs from 2018 ? Review of public administration and management omics from 4/2017 ? Journal of Pharmaceutics & Pharmacology aven 2016 ? GLS journal of clinical pathology 2017 ? Global scientific library ? Advances in Neurology and Neuroscience ? International Journal of Economics and Management Science March 2016 ? American journal of pharmacology and pharmacotherapeutics since 2016 ? Journal of Bioanalysis & Biomedicine ISSN: 1948-593X 2016 ? Modern approaches in drug design ? Journal of Infectious Diseases and Medical Microbiology ( allied acc. ) ? Journal of Pharmaceutical Chemistry and Pharmacology ? Journal of Biomedical and Pharmaceutical Sciences ? Statistical editor role from 8/9/2016 for 1 year in Universal journal of pharmaceutical research www.ujpr.org ? Intern medicine open access (from 9/2017) ? Open access journal of addiction and psychology IRIS pub ? Open access journal of toxicology juniper ( 2017 since Nov. 2018) Conferences –congress role • International advisory committee: at ICFPSR – 2017 Columbia Institute of pharmacy 2nd International Conference " Frontier in Pharmaceutical Sciences and Research" RABIPUR INDIA ? Innovate dementia 2017 board membership Brisbane Australia ? 5th International Conference on Clinical Pharmacy and Healthcare IT March 30-31, 2018 Orlando, Florida, USA o Board member ? TOXICOLOGY 2018 ROME POSTER PRESENTATION World Summit on Toxicology ROME 2018 brain response in some systemic immune condition- toxicological aspects SCIENTIFIC FEDERATION ? Regional antidotes annual congress 2018 BOLOGNA ITALY RER 11-6-2018 8 speaker role. ? MANY OTHER INVITE TO BE BOARD OF INTERNATIONAL CONGRESS IN MANY DISCIPLINE AS TOXICOLOGY, PHARMACOLOGY, NEUROSCIENCE ET OTHER ? World summit on toxicology Rome 2018 organizing committee membership SCIENTIFIC FEDERATION ? OFFICIALLY INVITED TO Euro Global Congress on Toxicology & Applied Pharmacology https://tychonixinternational.org/toxicology-europe ? OFFICIALLY INVITED TO World Congress of Regenerative Medicine & Stem Cell scheduled from December 7-9, 2018 CHINA
Clinical pharmacology, pharmacoeconomy, new professional social media , biomedical database , EBM
Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure
1) Identification and valid of pain molecules and signal transduction pathways; 2) Reverse pain pharmacology of herbal medicines; 3) Discovery and development of painkillers.